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Background: We have proposed a new scoring system (Anaphylaxis SCoring Aichi: ASCA) for a quanti-
tative evaluation of the anaphylactic reaction that is observed in an oral food challenge (OFC). Further-
more, the TS/Pro (Total Score of ASCA/cumulative protein dose) can be a marker to represent the overall
severity of a food allergy. We aimed to develop a prediction model for a severe allergic reaction that is
provoked in a boiled egg white challenge.
Methods: We used two separate datasets to develop and validate the prediction model, respectively. The
development dataset included 198 OFCs, that tested positive. The validation dataset prospectively
included 140 consecutive OFCs, irrespective of the result.
A ‘severe reaction’ was deﬁned as a TS/Pro higher than 31 (the median score of the development dataset).
A multivariate logistic regression analysis was performed to identify the factors associated with a severe
reaction and develop the prediction model.
Results: The following four factors were independently associated with a severe reaction: ovomucoid
speciﬁc IgE class (OM-sIgE: 0e6), aged 5 years or over, a complete avoidance of egg, and a total
IgE < 1000 IU/mL. Based on these factors, we made a simple scoring prediction model. The model
showed good discrimination in a receiver operating characteristic analysis; area under the curve
(AUC) ¼ 0.84 in development dataset, AUC ¼ 0.85 in validation dataset. The prediction model signiﬁ-
cantly improved the AUC in both datasets compared to OM-sIgE alone.
Conclusions: This simple scoring prediction model was useful for avoiding risky OFC.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Oral food challenges (OFC) have been performed for the deﬁn-
itive diagnosis of a food allergy and more frequently, for the
discernment of tolerance to the allergen.1 In addition to these
conventional purposes, OFCs are performed to determine the
threshold dose of food allergens for individuals beginning oral
immunotherapy (OIT) or to determine the threshold of minimal
avoidance. More severe reactions tend to be provoked in these OFC
settings.
Sampson's grade stratiﬁcation2 is commonly used for an
assessment of the severity of allergic reaction provoked in an OFC,Aichi Children's Health and
, Japan.
ety of Allergology.
rgology. Production and hosting by Elseand the Japanese Guideline for Food Allergy 2014 adopted it with
minor modiﬁcations.3 This classiﬁcation mostly aims to evaluate
the severity of a reaction to decide the indications for therapy
including intramuscular epinephrine injection. For that purpose,
severity is judged based on the highest grade of symptoms, even if
multi-organ reactions are provoked.
On the other hand, an evaluation of multi-organ symptoms can
be an important severity marker in some purposes because the
number of symptomatic organs involved in an allergic reaction
affects the outcome of achieving tolerance afterward.4,5 For this
purpose, we have developed an original scoring system named
Anaphylaxis Scoring Aichi (ASCA) for a quantitative evaluation of
multi-organ reactions provoked in OFCs.6 ASCA lists and sorts
allergic symptoms according to ﬁve organ systems (respiratory,
skin-mucosal, gastrointestinal, psycho-neurological, and cardio-
vascular). In the gastrointestinal symptoms, the degree of abdom-
inal pain was expressed as face scale (Supplementary Fig. 1). Each
symptom was given an organ system score of 0e60 points invier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. The correlation between total score of ASCA and Sampson's anaphylaxis
grading. ASCA, Anaphylaxis scoring Aichi. Adapted from Ref. 6 with modiﬁcation.
S. Sugiura et al. / Allergology International 65 (2016) 293e299294accordance to the severity. The gradient of the points was set for the
purpose that the sum of plural mild points does not exceed one
severe organ system point. The organ system score of 40 points
almost corresponds to grade 4 of Sampson's grade2 (Table 1).
The total score (TS) was deﬁned as the sum of 5 organ system
scores (maximum 240 points) based on the highest organ system
score observed throughout a course of OFC. We have already vali-
dated the TS to be correlated to Sampson's grade6 (Fig. 1).
Several studies have tried to predict the result of OFCs and their
severity of outcome. Although a probability curve of speciﬁc
Immunoglobulin E (sIgE) provides useful information for predicting
a positive challenge7 and a severe reaction,8 another report sug-
gested a limitation in its predictive accuracy.9 Component-resolved
diagnostics for wheat (u-5 gliadin)10 and peanut (Ara h 2)11 pro-
vided a promising prediction for the positive result of an OFC, but
failed to predict the threshold dose and the severity of symptoms.
Clinical backgrounds should also be considered to predict the
outcome of an OFC including the severity of the provoked
reactions.4,12,13
A recent article suggested that a complex model incorporating
both test results and a clinical history had a better predictive ability
compared to simply relying on the sIgE and skin prick test (SPT)
either alone or in combination with one another.4 For the purpose
of identifying a severe allergic reaction, a complexmodel is thought
to be a better predictor.12Table 1
Anaphylaxis scoring Aichi (ASCA).
Score organ 0 ① 1 point ① 5 points ② 1
Respiratory
(subjective）
None Itchy nose Laryngeal discomfort Nas
Suf
bre
(objective) Sneeze Mild transient
coughing
Runny nose
Inte
cou
Mil
Skin/Mucosal
(subjective)
None Itch (around mouth)
Mild discomfort,
Burning sensation
Itch (local and mild) Itch
(wh
(objective) <Peri-oral>
Hives, Erythema, Swelling,
Vesicle
<Local>
Eye edema, Bloodshot
Hives, Erythema,
Swelling, Angioedema
<M
Hiv
Swe
Ang
Gastrointestinal
(subjective)
None Oral or pharyngeal
itch, Hot taste,
Sore throat
Mild nausea,
Abdominal pain (FS1)
Mil
Abd
(FS2
(objective) Increased bowel
sounds
Dia
Vom
Psycho-
neurological
None Refusal to eat
Mild excitement
Loss of activity
Irritation
Slee
to l
Mil
Cardiovascular None
(Blood pressure)
Allergic symptoms are categorized into 5 organ systems, and each organ symptom scor
deﬁned as a sum of the highest organ symptom score observed throughout the course o
FS, Face scale to express the degree of abdominal pain (Supplementary Fig. 1).The aim of this study was to identify the clinical factors
contributing to a severe reaction provoked in an OFC and use them
to develop a prediction model.0 points ② 20 points ③ 40 points ④ 60 points
al congestion
focating
ath
Speech disturbance
Difﬁculty in
breathing
Loss of voice
rmittent
ghing
d wheezing
Frequent coughing
Apparent wheezing
Hoarseness
Continuous
coughing
Strong wheezing
Intentional breathing
Inspiratory stridor
Retraction
Weak breath
sounds
Strong retraction
Cyanosis
SpO2  90%
ole body)
unbearable itch
ultiple>
es, Erythema,
lling
ioedema
<Spreading,
Generalized>
Hives, Erythema,
Swelling
Angioedema
d nausea,
ominal pain
)
Strong abdominal
pain (FS3)
Unbearable
abdominal
pain (FS4)
rrhea,
iting
Recurrent vomiting Dehydration by
vomiting
p, Tendency
ay down
d excitement
Sleep (not usual)
Agitating, Crying
Tend to fall
unconscious
Uncontrolled panic
Unconsciousness
Pale, Tachycardia
Cold extremities,
Cold sweat
Bradycardia
Mild decrease of
blood pressure
<1 y: <70 mmHg
1e10 y: <70þ
(2 x age) mmHg
11e17 y: <90
Low Blood
Pressure
<1 y: <50 mmHg
1e10 y:
<60 mmHg
11 y:
<70 mmHg
e (0e60 points) is given based on the severity of the symptoms. Total score (TS) is
f allergic symptom (maximum 240 points).
S. Sugiura et al. / Allergology International 65 (2016) 293e299 295Methods
Oral food challenge (OFC)
An open OFC of 20 min-boiled egg white was performed ac-
cording to the Japanese Guideline for Food Allergy 2014.3 We
selected the consecutive 4 to 6 doses from 0.2, 0.5, 1, 2, 5, 10 and
20 g of boiled egg white depending on the age and estimated
severity of the patient. Every dosewas takenwithin 2 h (40e20min
intervals), but the challenge was stopped if the patient exhibited an
objective allergic reaction corresponding to 5 point ormore of ASCA
TS.
Anaphylaxis Scoring Aichi (ASCA)6
The severity of provoked symptoms was scored using the TS of
ASCA. Furthermore, we have developed a new indicator “TS/Pro”
for the simultaneous expression of severity and threshold dose of
antigen. “Pro” represents the cumulative protein dose of the
allergen that provoked symptoms, and the TS/Pro was obtained by
simply dividing the TS by Pro.
Dataset
The development dataset was obtained from OFCs to boiled egg
white from April 2012 to May 2013. During this period, 450 OFCs to
boiled egg white were conducted and 273 OFCs (60.1%) of those
were positive. To minimize a selection bias, only positive results
were chosen to develop a prediction model. The appropriate lab-
oratory data (sIgE to ovomucoid (OM) and total IgE) that was
collected during the 180 day period was missing in 75 of the cases.
As a result, data was included from 198 cases.
To validate this model in an independent clinical setting, 140
consecutive OFCs to boiled egg white (95 positive and 45 negative)
were analyzed from June 2013 to November 2013 in a prospective
manner.
Selection of the risk factors
The factors analyzed as a candidate for contribution to the
challenge result were age, sex, history of anaphylaxis to egg, history
of atopic dermatitis or bronchial asthma, present state of egg
avoidance, total IgE, egg white (EW)-sIgE, and OM-sIgE (Phadia AB,
Uppsala, Sweden). Doctors and dietitians carefully took the pa-
tient's dietary history to obtain information regarding egg avoid-
ance because parents often serve some foods containing egg (for
example, breads or cookies) unintentionally even if they declare
that they are striving to follow a diet of “complete avoidance of
egg”.
We divided patients in the development dataset into two groups
(severe cases and non-severe cases) on the basis of the median
value of the TS/Pro of the development dataset.
Development of the prediction model
For a univariate analysis, the ManneWhitney U test was used to
compare the sequential data and a chi-square analysis was used to
compare the binary variables. The factors selected from the uni-
variate analysis were then used for a multivariate regression anal-
ysis to identify the independent predictors of a severe allergic
reaction. For measuring OM-sIgE, which has the nature of a loga-
rithmic scale, the classiﬁcation of sIgE (0e6: Supplementary
Table 1) was applied. The values of OM-sIgE below 0.34 UA/mL
(class 0) and above 100 UA/mL (class 6) were dealt as 0.34 UA/mL
and 100 UA/mL, respectively. The values of OM-sIgE < 0.35 kUA/Land 100 kUA/L were determined to be 0.34 kUA/L and 100 kUA/L,
respectively. For age and total IgE, the cutoff points were deﬁned
approximately in the upper quartile of the individual variables.
Based on the results, we constructed a logistic regression model
using the independent factors with a probability value p < 0.05. We
next created a simple scoringmodel by assigning the point scores of
each variable. The discriminatory capacity of the model was
assessed using the area under the receiver operating characteristics
(ROC) curve. Comparing area under the curve of the ROC curve, we
accepted the method proposed by DeLong et al.14 The goodness of
ﬁt of the regression model was tested with the HosmereLemeshow
test, with p < 0.05 indicating a lack of deviation between the model
and observed event rate.
This study was approved by the institutional review board of
Aichi Children's Health and Medical Center. All analyses were per-
formed with the STATA (version 12.1 for Mac; STATA Inc, College
Station, TX, USA) software program. For all analyses, a 2-sided
probability value below 0.05 was considered to indicate statistical
signiﬁcance.
Results
Selection of the factors associated with the severe result of OFC
Characteristics of the development dataset are shown in Table 2
and Figure 2. The median age of the dataset was 3.95 years and
67.2% were males. The median TS was 15 points and the median
cumulative dose of egg white was 3.7 g, thus resulting in a median
TS/Pro of 31.2. According to this result, we deﬁned the severe cases,
as TS/Pro > 31, (n ¼ 101) and non-severe cases (n ¼ 97).
A univariate analysis identiﬁed 5 variables (EW-sIgE, OM-sIgE,
complete avoidance, age, total IgE) as they showed a signiﬁcant
or marginally signiﬁcant difference between the severe and non-
severe groups (Table 2).
EW-sIgE and OM-sIgE showed a strong correlation (Spear-
man's R ¼ 0.88) and they both showed statistically signiﬁcant
correlation to the TS/Pro (Spearman's R ¼ 0.42 and 0.53,
respectively, both p-value < 0.01, Fig. 3). Therefore, we selected
OM-sIgE, but not EW-sIgE, as the candidate for the multivariable
analysis to avoid multicovariance. To evaluate the validity of
dealing with OM-sIgE (class) as numerical variables, the associ-
ation between logistic coefﬁcient (b) of OM-sIgE (class) and se-
vere cases was conﬁrmed.
Development of the prediction model
Based on the results from the univariate analysis, the four
variables, “OM-sIgE class (0e6)”, “complete avoidance”, “total
IgE < 1000 IU/mL (upper quartile of the level)” and “5 years or
more (upper quartile of age)” were included in the multivariate
logistic regression analysis (Table 3). The result of the logistic
regression analysis revealed these four factors to be indepen-
dently associated with the result of OFC, which enabled us to
construct a logistic regression model and a simple scoring model
by approximating the logistic coefﬁcients (b). The prediction
score consisted of the base point of OM-sIgE (1 point/class), one
point each for the total IgE < 1000 IU/mL and an age of 5 years or
more, and 2 points for complete avoidance, resulting in a
maximum of 10 points.
The prediction score showed a signiﬁcant correlation to the TS/
Pro (Fig. 4). The median score of the development dataset was 6
(ranging from 0 to 10). The area under the ROC curve was 0.84 (95%
CI, 0.79 to 0.90) for the simple scoring model, which was almost
identical to that obtained from the logistic regression model 0.86
(95% CI, 0.79 to 0.90). The HosmereLemeshow statistic was not
Table 2
Background characteristics of the development and validation dataset.
Development dataset Validation dataset
Total Severe
(TS/Pro > 31)
Non-severe p-value Total Severe
(TS/Pro > 31)
Non-severe or
negative result
p-value
Number 198 101 97 140 49 91
Age 3.95 (2.5e6) 4.7 (3e6.3) 3.3 (2.2e5.5) 0.002 4.15 (2.6e6.1) 5 (2.9e5.8) 3.5 (2.2e6.4) 0.30
Male 133 (67.2%) 67 (66.3%) 66 (68.0%) 0.80 97 (69.3%) 32 (65.3%) 65 (71.4%) 0.45
Atopic dermatitis 147 (74.2%) 74 (73.3%) 73 (75.3%) 0.75 103 (73.6%) 37 (75.5%) 66 (72.5%) 0.70
Bronchial asthma 58 (29.3%) 33 (32.7%) 25 (25.8%) 0.29 44 (31.4%) 23 (46.9%) 21 (23.1%) <0.01
History of anaphylaxis 31 (15.7%) 18 (17.8%) 13 (13.4%) 0.39 20 (14.3%) 11 (22.4%) 9 (9.9%) 0.04
Complete avoidance 162 (81.8%) 95 (94.0%) 67 (69.1%) <0.001 104 (74.3%) 46 (93.9%) 58 (63, 7%) <0.001
Total IgE (IU/mL) 439 (150e968) 507 (197e1008) 386 (110e922) 0.07 504 (192e1031) 590 (266e1115) 432 (183e1021) 0.25
EW-sIgE (kUA/L) 22.5 (7.9e44.4) 32.6 (17.4e75) 10.2 (4.3e25.7) <0.001 15.3 (6.3e39.4) 30.5 (14.2e59.1) 9.24 (5.09e24.3) <0.001
OM-sIgE (kUA/L) 11.45 (3.3e34) 22.4 (11.3e44.8) 3.49 (1.7e12.3) <0.001 7.12 (2.2e21.0) 18.5 (8.3e40.3) 3.4 (1.1e9.7) <0.001
Total score of ASCA 15 (10e30) 25 (15e35) 10 (5e15) <0.001 5 (0e15) 16 (15e30) 1 (0e5) <0.001
Total amount of the
boiled egg white (g)
3.7 (1.7e8.8) 1.7 (0.7e3.6) 8.8 (8.5e18.5) <0.001 3.7 (1.7e18) 1.7 (0.7e1.7) 8.7 (5.5e18.5) <0.001
TS/Pro 31.2 (7.4e118) 118 (59.8e265.5) 7.4 (3.5e15.6) <0.001 9.0 (0e69.5) 104.1 (63.2e189.6) 0.23 (0e5.3) <0.001
Values are presented as medians (ﬁrst and third quartiles) or number (proportion). Each p-value is calculated using the ManneWhitney U test (sequential variables) or chi-
square test (binary variables). EW, egg white; OM, omucoid; sIgE, speciﬁc IgE.
Fig. 2. Individual results of boiled egg white challenge. The scatter plot shows the
distribution of cumulative protein dose (g of egg white protein) and the total score of
ASCA in the development dataset (n ¼ 198). The reference line indicates the total score
40 points.
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and the simple scoring model, respectively). The simple scoring
model was signiﬁcantly superior in its discriminatory ability for
predicting severity (AUC ¼ 0.84) in comparison to the prediction
obtained using the OM-IgE class alone (AUC¼ 0.79) (p < 0.01, Fig. 5,
left).
Validation of the prediction model
The background characteristics of the validation dataset are
shown in Table 2. Among 17 OFCs with a prediction score 8 and
over, 13 OFCs (76.5%) resulted in a severe reaction (TS/Pro  31). On
the other hand, 59/60 OFCs (98.3%) with a prediction score 5 and
under presentedwith a non-severe reaction or negative results. The
sensitivity and speciﬁcity of each cutoff is shown in Supplementary
Table 2.
In this dataset, the area under the ROC curve was 0.85 for the
simple scoring model, which was superior in its discriminatory
ability in comparison to the OM-sIgE class alone (p ¼ 0.011, Fig. 5,
right) and the HosmereLemeshow statistic was not signiﬁcant (p
¼ 0.063).Discussion
We have developed the original severity score of allergic
symptoms, named ASCA, and deﬁned the overall severity indicator
‘TS/Pro’. By using this index, we identiﬁed the factors associated
with severe results (low threshold and high symptom scores) in
OFCs to boiled egg white. Furthermore, we developed a simple
prediction model for a severe allergic reaction in OFCs. The model
was constructed using the OFC positive dataset and the discrimi-
native ability of this model was validated in another dataset
including challenge-negative cases.
In the present study, OFCs were performed even for patients
with a high probability for positive results, unless a recent
anaphylaxis eventwas experiencedwith a small amount of allergen
exposure. We aimed to ﬁnd a safe dose of allergen ingestion, even
among the challenge-positive patients, according to the basic
strategy written in the Japanese guidelines.3 However, we needed
to avoid dangerous and ineffective challenges with a low proba-
bility of ﬁnding the safe dose of allergen ingestion.
For the purpose of predicting such severe cases, we analyzed
factors associated with severe cases and developed prediction
model. We included only positive OFCs (60.7% of the total OFCs) to
develop the prediction model. This was because the ﬁnal dose was
limited to a small amount for the safety of severely allergic patients
and the true TS/Pro might not be zero if a larger amount was
applied.
The developed model was validated in another dataset
including both positive and negative results. Although sufﬁcient
discrimination ability was reproduced in the validation dataset, the
Hosmer-Lemeshow goodness of ﬁt test of the simple scoring model
was marginally signiﬁcant (p ¼ 0.0629). This was partially due to
the bias of our clinical policy, in which we tended to decrease the
ﬁnal dose of an OFC for any patient that was predicted to have a
severe reaction, thus resulting in a negative result.
We selected the OM-sIgE titer instead of EW-sIgE as a speciﬁc
IgE to predict a severe reaction. For identifying a positive OFC of
boiled egg white, the OM-sIgE was reported to be superior to EW-
sIgE.15,16 We have evaluated the severity of allergic reactions in
positive challenges and found that OM-sIgE correlated to the TS/Pro
better than EW-sIgE. In our data, sIgE values had an upper limit of
100 UA/mL [class6]. If the true values of >100 UA/mL could be
applied, the Rs would be higher.
Nomura et al. reported a probability curve of OM-sIgE to predict
a severe allergic reaction in an egg OFC, but the threshold dose was
0.1
1
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100
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0.1 1 10 100
0.1
1
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100
1000
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Egg white-specific IgE (UA/mL) Ovomucoid-specific IgE (UA/mL)
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/P
ro
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/P
ro
Fig. 3. Correlation between speciﬁc IgE and the TS/Pro. Ovomucoid-speciﬁc IgE correlated to the TS/Pro (right, Rs ¼ 0.53, p < 0.01) better than egg white-speciﬁc IgE (left, Rs ¼ 0.42,
p < 0.01). TS/Pro, Total Score of ASCA/cumulative protein dose.
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correlation between OM-sIgE and the severity of reaction taking
the threshold dose into account.
Low total IgE value (<1000 IU/mL) was identiﬁed as a risk factor
for severe allergic reactions. Christensen LH et al. reported that
non-speciﬁc or low-afﬁnity IgE suppresses the speciﬁc IgE-
mediated activation of basophils in vitro.17 The low total IgE
values were also reported to be associated with positive and severe
reactions in a venom allergy18 and the results of OFCs.19
An older age was also one of the risk factors for a severe allergy.
This result might not be ubiquitous in other settings. We have
repeated OFCs to the challenge-positive patients almost once a
year. As a result, the older patients represented the selection of
patients with a refractory allergy.
“Complete avoidance” was identiﬁed as a risk factor for a severe
allergic reaction. There could be two reasons for this ﬁnding. One is
a screening effect of the patients who were already tolerant to a
small amount of antigen. Another reason may be an immunother-
apeutic effect from ingesting antigen. Studies of low-dose oral
immunotherapy or sublingual immunotherapy have suggested the
effect of ingesting a small amount of antigen to increase the
threshold dose.20
For patients with food allergies, the only accepted management
worldwide has been the complete avoidance of the allergen.21
Many studies have reported the efﬁcacy of OIT,22e30 but not all
patient who performed an OIT could gain tolerance without difﬁ-
culty. Vazquez-Ortiz et al. reported that patients with a low
threshold in the beginning tended to exhibit severe reactions
during an OIT and could not tolerate the allergen easily.31Table 3
The multivariable logistic analysis of the development dataset and the score points
given in a simple scoring system.
Logistic
Coefﬁcient
(b)
SE OR
(adjusted)
P-
value
Score
point
OM-sIgE (class 0e6) 1.18 0.20 3.26 <0.001 1
Complete avoidance 1.69 0.57 5.42 0.003 2
Total IgE < 1000
IU/mL
1.58 0.51 4.80 0.002 1
Aged 5 years or
more
0.94 0.39 2.55 0.02 1
OM, ovomucoid; sIgE: speciﬁc IgE.We usually instruct the patients with a low TS/Pro to start a
small amount of ingestion.32 This dietary instruction is applied to a
patient expected to ingest 2 g or more of boiled egg white safely.
After determining the safety of the initial dose at the follow-up
visit, we allow them to increase the dose slowly. In this practice,
many patients achieved tolerance sooner than those remained on
elimination diet.33
On the other hand, patients with higher TS/Pro generally need to
continue complete avoidance. The cut-off level of TS/Pro at 31 was
almost equivalent to our instruction policy of complete avoidance.
For example, when a patient presented with multiple urticaria,
intermittent cough and vomiting (TS ¼ 30) after ingesting 8.7 g of
boiled egg white (protein 0.98 g), the TS/Pro becomes 30.6.
We examined some other models using alternative cutoff value
of TS/Pro or score point assigned to each factor to validate our
prediction model. As a result, no other models showed superior
discrimination ability with statistical signiﬁcancy and suitability in
the clinical use.
Based on the ﬁndings of the present study, we do not recom-
mend performing an OFC for patients with a prediction score of 8
and over. If you decide to perform an OFC to the patient, you mayTS
/P
ro
PredicƟon score
Fig. 4. Correlation between the prediction score and the TS/Pro. The box plots of TS/
Pro in each prediction score are shown. The line at TS/Pro ¼ 31 indicates the median
level of the development dataset (n ¼ 198). The prediction score signiﬁcantly corre-
lated to the TS/Pro (Rs ¼ 0.65, p < 0.01).
Fig. 5. A ROC analysis of the prediction score and speciﬁc IgE class. In the development dataset (left), the prediction score (diamond, dash line, AUC ¼ 0.84) showed a better
discrimination ability (p < 0.01) of a severe result of OFC than the ovomucoid-speciﬁc IgE class (Circle, Solid line, AUC ¼ 0.79). The result was reproduced in the validation dataset
(right); AUC ¼ 0.85 and 0.78, respectively (p ¼ 0.011). ROC, Receiver Operating Characteristic; AUC, area under the curve.
S. Sugiura et al. / Allergology International 65 (2016) 293e299298better restrict the dose of antigen for a safer OFC. However, if an
OFC is nevertheless performed on these patients, then a smaller
dose of antigen should be used for safety reasons.
On the other hand, pediatric allergists may generally perform an
OFC for patients with a prediction score 5 and under, because se-
vere reactions might be unexpected. As a result, the ingestion of a
small amount of allergen may be given safely.
One limitation of the current study is that it was conducted only
at one center specialized for food allergy. The indication of an OFC
in our department might have affected proportion of positive result
in OFCs, and the cut-off level of a severe allergic reaction (TS/
pro > 31). This prediction model can be applied only to an OFC
using 20 min boiled egg white because we have not evaluated the
data with other egg products or other food allergens. We are now
creating the corresponding prediction model for cow's milk and
wheat allergens.
In conclusion, our prediction model showed a good discrimi-
nation of severe allergic reaction based on the TS/Pro. It may
therefore be clinically effective for many pediatric allergists to
avoid a high-risk OFC and instead encourage a low-risk OFC.
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